Literature DB >> 2936776

Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study.

F F Soeprono, R A Schinella, C J Cockerell, S L Comite.   

Abstract

We studied twenty-five skin biopsies from twenty-one patients with acquired immunodeficiency syndrome or its prodrome who presented with the "seborrheic dermatitis" associated with acquired immunodeficiency syndrome and compared them with an equal number of biopsies from patients with seborrheic dermatitis who had neither acquired immunodeficiency syndrome nor its risk factors. We found that although the eruption in acquired immunodeficiency syndrome closely resembles seborrheic dermatitis, histologically it is distinctive because it shows spotty keratinocytic necrosis, leukoexocytosis, and a superficial perivascular infiltrate of plasma cells and, frequently, neutrophils that show occasional leukocytoclasis. In long-standing lesions, hyperkeratosis is often present. None of these histologic features are commonly encountered in seborrheic dermatitis, psoriasis, or other eruptions known to us.

Entities:  

Mesh:

Year:  1986        PMID: 2936776     DOI: 10.1016/s0190-9622(86)70028-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Dermatological conditions in HIV infection.

Authors:  M M Walker; C E Griffiths; J Weber; J N Leonard; S M Forster; A V Powles; J R Harris; R J Clayton
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

2.  Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting.

Authors:  Y K Sharma; Mps Sawhney; D S Bhakuni; V Gera
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Altered serum elements, antioxidants, MDA, and immunoglobulins are associated with an increased risk of seborrheic dermatitis.

Authors:  Ishrat Jahan; Md Rabiul Islam; Md Reazul Islam; Rubaiya Ali; S M Matiur Rahman; Zabun Nahar; Abul Hasnat; Md Saiful Islam
Journal:  Heliyon       Date:  2021-03-28

Review 4.  The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials.

Authors:  Odeh Alsmeirat; Som Lakhani; Musab Egaimi; Osama Idris; Mohamed Elkhalifa
Journal:  Cureus       Date:  2022-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.